Correlation Engine 2.0
Clear Search sequence regions


  • cell death (1)
  • cellular (1)
  • FDA (1)
  • humans (1)
  • iodates (2)
  • layers (1)
  • PARP (1)
  • PARP1 (8)
  • parp1 protein, human (1)
  • patients (1)
  • PIC (10)
  • pigment (3)
  • protein human (1)
  • protein rat (1)
  • rabbits (2)
  • rat (3)
  • sodium (3)
  • Sizes of these terms reflect their relevance to your search.

    Poly (ADP-ribose) polymerase 1 (PARP1)-dependent cell death in the retinal pigment epithelium (RPE) is implicated in dry age-related macular degeneration (AMD). Although PARP1 inhibitors are available for treating dry AMD, their delivery route is not ideal for patients. The aim of this study was to test the efficacy of a novel PARP1-inhibitory compound (PIC) in vitro and in vivo. This study presents PIC, a novel small molecule, with superior efficacy to PARP1 inhibitors in the market. PIC demonstrated a distinctive inhibitory profile against PARP isotypes than the FDA-approved PARP1 inhibitors. PIC inhibited PARP1 activation at an IC50 of 0.41 ± 0.15 nM in an enzyme-based assay in vitro and at IC50 and EC50 in ARPE-19 cells of 0.11 ± 0.02 nM and 0.22 ± 0.02 nM, respectively, upon H2O2 insult. PIC also moderated mitochondrial fission and depolarization and maintained cellular energy levels under oxidative stress in ARPE-19 cells. Furthermore, PIC demonstrated good corneal penetration in a rat model, presenting PIC as a promising candidate for eye drop therapeutics for dry AMD. When PIC was administered as an eye drop formulation, RPE morphology was preserved, maintaining the thickness of the outer nuclear layers under sodium iodate (SI) treatment in rats. In SI-treated rabbits, eye drop administration of PIC also retained the structural and functional integrity when analyzed using funduscopy and electroretinogram. Collectively, our data portray PIC as an attractive treatment measure for dry AMD. Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

    Citation

    Jeongmin Ho, Ki-Hong Jang, Tae-Sung Koo, Changmin Park, Young-Hoon Kim, Juhee Lee, Eunhee Kim. Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 Jan;133:111041

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33378949

    View Full Text